Home

Mesothelioma

• About Mesothelioma
• Mesothelioma Cause
• Mesothelioma Symptoms
• Mesothelioma Diagnosis
• Mesothelioma Stages

Mesothelioma Treatment

• Treatment Options
• Mesothelioma Surgery
• Mesothelioma Chemotherapy
• Mesothelioma Radiation
• New Approaches
• Palliative Care

Mesothelioma Specialists

• Choosing Your Doctor
• Your Health Care Team
• Cancer Centers

Clinical Trials

• Trial Basics
• Eligibility
• Current Trials

Managing Your Care

• Your Personal Records
• Your Medications
• Your Expenses

Veterans Resources

• Veterans' Mesothelioma Home
• Asbestos Exposure
• Asbestos Diseases
• VA Health Care
• Veterans Service Officers

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

1. Scientists Find Cell Process That Causes Mesothelioma
2. Immune Response Inhibitor Identified in Cancer Retroviruses
3. MRIs Effective in Identifying Malignant Testicular Cancer Growths
4. National Comprehensive Cancer Network Announces New Mesothelioma Guidelines
5. New Type of Cancer Vaccine May Revolutionize Treatment of Some Cancers
6. Survey Sheds Light on Severity of Breakthrough Cancer Pain
7. Mesothelioma Vaccine Proven Safe
8. Personalized Mesothelioma Vaccine Tested in Humans - article at Oncolink
9. New Treatments for Mesothelioma Show Promise
10. Cancer Scientists Isolate Fingerprint of Individual Tumors
11. High Cancer Costs Keep Patients From Seeking Treatment
12. Clinical Trials Starting Soon for Mesothelioma Drug
13. Mesothelioma Drug Phase II Trials Starting Soon in Australia
14. Targeting B-Cell Surface Proteins to Fight Cancer
15. Mesothelioma and Cancer Research - Human Epidermal Growth Factor Receptor (HER) Signaling and Cancer Therapy
16. Preparing for surgery - details to consider
17. Mesothelioma and Cancer Research - the Hedgehog signaling pathway and cancer therapy
18. Predicting the Effectiveness of Avastin
19. New Mesothelioma Detection Test Ready for Distribution
20. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
21. New Maintenance Therapy Methods for Lung Cancer
22. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
23. New Chemotherapy Combination to be tested on Mesothelioma Patients
24. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
25. Finnish Study Could Lead to Better Lung Cancer Drug
26. New Lung Cancer Drug Starts Phase II Clinical Trial
27. Gene Screening Proves Effective in Screening for Mesothelioma Survival
28. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
29. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
30. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
31. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
32. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
33. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
34. Cancer Diagnosis From a Single Drop of Blood?
35. National mesothelioma virtual bank
36. Another Study Links Nanotubes To Mesothelioma
37. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
38. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
39. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
40. Research Shows Altered Immune Cells Target Mesothelin
41. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
42. Breakthrough Could Lead to New Cancer Therapies
43. Gene Fusions May Be Unique Identifier for Cancer
44. Study Examines Interactions Between Asbestos Fibers and Cells
45. Liver Tumors Treated with Chemotherapy Beads
46. Mesothelioma Researcher Receives Two Grants
47. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
48. Synthetic Material Attaches to Cells to Assist in Cancer Research
49. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
50. FDA Recommends Additional Clinical Trial for Onconase
51. ZenBio Awarded Phase II SBIR Grant for Cell Development
52. Researchers gain new insight into DNA replication
53. Study bolsters argument for treating cancer-related fatigue with exercise
54. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
55. Researchers report promising gene that causes cancer cells to self destruct
56. EPA awards $2.1 million asbestos research grant
57. Cancer research may exclude older patients
58. Vitamin supplements may not help prevent cancer
59. New treatments under development for asbestos-related cancer
60. Cancer treatment errors happen more than commonly known
61. Scientists develop nanotube technology to fight cancer cells
62. Study Shows Brief Inhibition of Cancer Cells is Effective
63. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
64. Vitamin trials for cancer prevention offer disappointing results
65. Supressing tumors in young patients may increase cancer risk in later years
66. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
67. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
68. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
69. Clinical trials struggling to attract participants
70. Study finds chemotherapy may be harmful For patients with advanced cancer
71. New cancer studies call anti-angiogenesis process into question
72. Scientists explore ways to use genes to fight cancer
73. Researchers find molecule that causes malignant cells to self-destruct
74. Research sheds light on lung cancer for non-smokers
75. Doctors look toward screening for lung cancer
76. Nanomaterial Screening helps determine which particles are toxic
77. Experts: Current pain treatment not sufficient for cancer patients
78. Massage could be beneficial for reducing cancer pain
79. New findings about chemotherapy at the molecular level
80. Transdermal patch developed for severe cancer pain
81. Too much Vitamin C may interfere with chemotherapy
82. New clues on causes of thoracic cancer
83. Telomerase gene sequence uncovered
84. Pleurodesis in the treatment and care of mesothelioma patients
85. Epigenetic drugs for cancer treatment
86. Study shows Alimta effective for maintenance therapy
87. Scientists announce advance in immunotherapy
88. Minimally invasive RFA treatment could be used for several cancer types
89. Novel strategy for cancer treatment uses patient's own blood
90. Attacking cancer stem cells a way to treat cancer
91. Predicting cancer-fighting abilities by computer
92. Anti-inflammatory drugs investigated for chemoprevention
93. Modified chemotherapy agent improves PET scan functioning
94. Government budget cuts deter progress in fight against cancer
95. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
96. Tumor Generator Could Enhance Cancer Drug Development
97. Belgian doctors hit personalized cancer treatment milestone
98. New biomarkers for cancer developed
99. New cancer medicines track records fail to live up to hype
100. New research initiative to map genetic mutations behind cancer
101. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
102. Personalized medicine holds promise
103. Arenegyr Receives Orphan Drug Designation for Mesothelioma
104. Onconase Phase IIIb Trial Posts Mixed Results
105. Study finds inaccuracies in some cancer treatment research.
106. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
107. New Study Tells Researchers How Cancer Spreads
108. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
109. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
110. Synthetic Molecules May Help Battle Cancer
111. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
112. Exercise Shown to Fend Off Fatigue Caused by Cancer
113. Nanoparticles Could Deliver Cancer Drugs
114. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
115. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
116. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
117. "Bacteria Therapy" Shows Promise in Initial Tests
118. New UCLA Machine May Kill Cancer Cells
119. Study raises doubts about some DNA-based drugs
120. Disease-Causing Bugs May Help Treat Cancer
121. New Cancer Vaccine Approved for Limited Use in Russia
122. New Therapy Targets Hepatitis C
123. Innovative New Cancer Treatment Idea Earns $1 Million Prize
124. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
125. Nanoparticles Help Advance Anticancer siRNA Therapy
126. Research at MIT Shows microRNA's Protective Role
127. Patients See Benefit From Self Reporting Symptoms Online
128. Cancer drugs from genetically modified chicken eggs
129. Researchers attempting to figure out how cancer grows
130. Antifolates - Chemotherapy drugs
131. Dopamine for cancer treatment
132. Concerns about anemia medications for cancer patients
133. Researchers Developing New Ways of Detecting Cancer
134. Recentin Study Ends
135. Phase II Study of Sutent ® Results Out
136. Terminally Ill Cancer Patients Given Hope in UK
137. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
138. PET Found to be effective in the Evaluation of Cancer Treatment
139. One-tird of cancer patients experience chronic fatigue after treatment
140. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
141. New DNA Discovery Changes the Way Doctors Look at Cancer.
142. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
143. Mouse Model For Mesothelioma Reproduces Human Disease
144. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
145. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
146. Remembering a researcher’s legacy on asbestos research
147. PET proves effective in evaluating cancer treatment
148. Trial on experimental antifolate PDX (Pralatrexate)
149. American College of Physicians releases guidelines for end-of-life care
150. Web-based system helps doctors track outpatients’ chemotherapy toxicity
151. NICE Gives Final Approval for Alimta
152. Par Pharmaceuticals licenses Onconase
153. Thalidomide and Alimta to be Combined in New Clinical Trial
154. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
155. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
156. Boysenberries might impede mesothelioma
157. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
158. New Mesothelioma Research Center to Open in Sydney
159. Virotherapy to Treat Mesothelioma
160. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
161. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
162. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
163. Researchers Identify Intracellular Pathway of Alfacell's Onconase
164. New Study Heralds Shortened Timeline for Anticancer Drug Development
165. Talcum Powder Stunts Tumor Growth
166. Soluble mesothelin in effusions a strong indicator of mesothelioma
167. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
168. New Technology For Cancer Screening Listens For The Signs Of Cancer
169. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
170. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
171. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
172. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
173. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
174. Study shows Mesomark effective for monitoring Mesothelioma
175. FDA Grants Orphan Drug status to Onconase for Mesothelioma
176. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
177. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
178. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
179. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
180. Zolinza becomes first approved HDAC inhibitor
181. Alimta Researchers Recognized As Heroes Of Chemistry
182. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
183. FDA tells Eli Lilly that their Alimta brochure is misleading
184. News about onocology product candidate SS1P (renamed CAT-5001)
185. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
186. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
187. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
188. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
189. Scientist Reveals His Hopes for Better Tumour Treatment
190. Alfacell Drug Trial Ahead of Schedule
191. Alfacell Forms New Thoracic Cancer Advisory Board
192. Update on Onconase Clinical Program
193. Promising Research in Early Detection of Mesothelioma
194. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
195. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
196. Gene Drug Gives Mesothelioma Patient Second Chance
197. Novel therapies for pleural mesothelioma
198. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)

MesotheliomaWeb News Stories

Read excerpts from medical publications

News

• Mesothelioma News
• International News
• Pharmaceutical News
• Environmental News
• Medical Journal Articles

Resources

• Leading Cancer Links
• Financial Assistance, Compensation, and Legal Rights
• About Us
• Privacy Policy
• Disclaimer and Sponsorship Information

This site complies with the HONcode standard for trustworthy health information: verify here

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376